ESTRO 2024 - Abstract Book

S626

Clinical - Breast

ESTRO 2024

5. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. The Lancet. 1996;348(9029):708-13.

6. Holli K, Hietanen P, Saaristo R, Huhtala H, Hakama M, Joensuu H. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. Journal of clinical oncology. 2009;27(6):927-32. 7. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-106. 8. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet (London, England). 2011;378(9804):1707-16.

9. McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. Journal of Nuclear Medicine. 2016;57(Supplement 1):9S-16S.

10. Warrier S, Tapia G, Goltsman D, Beith J. An update in breast cancer screening and management. Women’s Health. 2016;12(2):229-39.

11. Neugut AI, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ. Lung cancer after radiation therapy for breast cancer. Cancer. 1993;71(10):3054-7.

12. Cook LS, White E, Schwartz SM, McKnight B, Daling JR, Weiss NS. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes & Control. 1996;7(3):382-90.

13. Evans H, Lewis C, Robinson D, Bell C, Møller H, Hodgson S. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. British journal of cancer. 2001;84(3):435-40.

14. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. National Cancer Institute Monograph. 1985;68:99-112.

15. Soerjomataram I, Louwman W, de Vries E, Lemmens V, Klokman W, Coebergh J. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972 – 2001. Breast cancer research and treatment. 2005;93(1):91-5.

16. Storm H, Jensen O. Risk of contralateral breast cancer in Denmark 1943-80. British journal of cancer. 1986;54(3):483-92.

17. Volk N, Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes & Control. 1997;8(5):764-70.

18. Ahsan H, Neugut AI. Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Annals of internal medicine. 1998;128(2):114-7.

19. Cozen W, Bernstein L, Wang F, Press M, Mack T. The risk of angiosarcoma following primary breast cancer. British journal of cancer. 1999;81(3):532-6.